URLs : Tickets: Brochure: Time : 9:30 AM - 4:40 PM Prices : Drug Developer - Conference + Workshop Day: USD 4397.00, Academic - Conference + Workshop Day: USD 3797.00, Solution Provider - Conference + Workshop Day: USD 5397.00, Drug Developer - Conference Only: USD 3099.00, Academic - Conference Only: USD 2699.00, Solution Provider - Conference Only: USD 3899.00 Speakers : Alok Pachori, Medical Director, Global Development, AstraZeneca, Kristin Fiorino, Medical Director, AstraZeneca, Fady Botros, Associate Vice President, Cardiometabolic Health Clinical Research Design, Eli Lilly, Belle Van Rosmalen, Director, Medical Development, Eli Lilly, Maria Trujillo, Senior Director, Quantitative Pharmacology and Pharmacometrics, Merck, Allison Goldfine, Executive Director, Translational Medicine, Cardiovascular and Metabolism, Novartis BioMedical Research, Rosemarie Sellati, Senior Director, Global Patient Advocacy, Regeneron, Adriana Ramos, Principal Scientist and Head of Lab, Sanofi, Bryan Jones, Chief Operating Officer, Aardvark Therapeutics, Steffen-Sebastian Bolz, Co-Founder, Executive Board Member and Chief Scientific Officer, Aphaia Pharma, Dr
J Intern Med 282(4):322331
Their ability to modulate biological repair mechanisms at a cellular level aligns perfectly with the goals of modern orthobiologic care: faster healing, fewer side effects, and better long-term outcomes
On molecular steps that activate a voltage sensitive ion channel at critical depolarization
Vilsboll T, Knop FK (2008) Long-acting GLP-1 analogs for the treatment of type 2 diabetes mellitus
